These trends are reshaping how carriers deploy capacity and how clients access coverage
If their insulin dose has not been adjusted to account for the ongoing insulin-sensitizing effect, they may experience hypoglycemia well after the exercise session ends
GLP-1 Orders for Overweight or Obese Patients Q1 2026 Quarterly rates per 100,000 of patients with an overweight or obese BMI receiving a prescription, dispense, or reporting starting a GLP-1 medication
Follow these steps exactly, in order, every time
Dosing ranges from 0.25 mg to 2.4 mg weekly for semaglutide, 0.75 mg to 4.5 mg weekly for dulaglutide, and 0.6 mg to 3 mg daily for liraglutide, with your healthcare provider determining the optimal dose based on glycemic control, tolerability, renal function, and cardiovascular risk factors
What you cant do with standard medication forms is change the preset dosage